InvestorsHub Logo
icon url

Investor2014

02/13/21 1:14 AM

#298733 RE: vg_future #298732

You do indeed have to put it in the right context, which is Missling’s answer from your own post.

“...the compassionate use program in Australia has the benefit that it allows for patients who are on the clinical study....”

I simply cannot comprehend how anyone can read beyond that in anything Anavex have communicated.
icon url

powerwalker

02/13/21 7:33 AM

#298743 RE: vg_future #298732

vg, FWIW - for those who might be invested in RLFTF, Ram Selvaraju of H.C. Wainwright is its CEO.